NO744621L - - Google Patents

Info

Publication number
NO744621L
NO744621L NO744621A NO744621A NO744621L NO 744621 L NO744621 L NO 744621L NO 744621 A NO744621 A NO 744621A NO 744621 A NO744621 A NO 744621A NO 744621 L NO744621 L NO 744621L
Authority
NO
Norway
Prior art keywords
group
compound
formula
alkyl
acid
Prior art date
Application number
NO744621A
Other languages
English (en)
Norwegian (no)
Inventor
J Bradshaw
M C Cook
G I Gregory
J D Cocker
D R Sutherland
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB59517/73A external-priority patent/GB1496757A/en
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of NO744621L publication Critical patent/NO744621L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO744621A 1973-12-21 1974-12-20 NO744621L (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives
GB4300574 1974-10-03

Publications (1)

Publication Number Publication Date
NO744621L true NO744621L (me) 1975-07-21

Family

ID=26265028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO744621A NO744621L (me) 1973-12-21 1974-12-20

Country Status (15)

Country Link
JP (1) JPS5844675B2 (me)
AT (1) AT344888B (me)
CH (1) CH617703A5 (me)
DE (1) DE2460537C2 (me)
DK (1) DK674674A (me)
ES (2) ES433226A1 (me)
FI (1) FI65258C (me)
FR (1) FR2255076B1 (me)
HU (1) HU172234B (me)
IE (1) IE42144B1 (me)
IL (1) IL46302A (me)
LU (1) LU71550A1 (me)
NL (1) NL7416665A (me)
NO (1) NO744621L (me)
SE (1) SE7416195L (me)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4095021A (en) 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4144392A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
US4165430A (en) 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4304770A (en) 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
GB1591439A (en) 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
GB1596278A (en) 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
PH17188A (en) 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
IT1126819B (it) * 1978-10-27 1986-05-21 Glaxo Group Ltd Antibiotici cefalosporinici,composizioni che li contengono e procedimento per produrli
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2552432B2 (fr) * 1983-09-27 1985-10-25 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Also Published As

Publication number Publication date
AT344888B (de) 1978-08-10
CH617703A5 (en) 1980-06-13
SE7416195L (sv) 1975-09-22
FI65258C (fi) 1984-04-10
IE42144L (en) 1975-06-21
DK674674A (me) 1975-09-08
IL46302A (en) 1978-09-29
NL7416665A (nl) 1975-06-24
HU172234B (hu) 1978-07-28
FI65258B (fi) 1983-12-30
LU71550A1 (me) 1976-04-13
DE2460537C2 (de) 1987-01-22
ES433226A1 (es) 1977-07-01
IL46302A0 (en) 1975-03-13
ATA1020174A (de) 1977-12-15
IE42144B1 (en) 1980-06-18
FI371374A (me) 1975-06-22
JPS50105689A (me) 1975-08-20
ES451604A1 (es) 1977-12-16
FR2255076A1 (me) 1975-07-18
AU7673574A (en) 1976-06-24
FR2255076B1 (me) 1978-11-10
DE2460537A1 (de) 1975-07-03
JPS5844675B2 (ja) 1983-10-04

Similar Documents

Publication Publication Date Title
FI67555C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbart (6 7r)-7-((z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxi imno)-acetamido)-3-(1-pyridiniummetyl)-cef-3-em-4-karboxyla t
NO744621L (me)
CS245753B2 (en) Production method of 7 beta-acylamido-3-cefem-4-carboxyle acids
FR2509310A1 (fr) Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
KR830000606B1 (ko) 세팔로스포린 항생제의 제조방법
US4103084A (en) 7-(Carboxy substituted α-etherified oximino arylacetamido) cephalosporins having a 3-vinyl or substituted vinyl group
DK147683B (da) Analogifremgangsmaade til fremstilling af cephalosporinforbindelser eller ugiftige salte, biologisk acceptable estere, 1-oxyder eller solvater deraf
HU182960B (en) Process for preparing cefem-carboxylic acid derivatives with antibiotic activity
US4074047A (en) 7 2-(Aminocarbonylalkoxyimino)acetamido! derivatives of cephalosporin
US4165430A (en) Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
NO793688L (no) Fremgangsmaate ved fremstilling av cephalosporinderivater
NO874690L (no) Fremgangsmaate for fremstilling av antibakterielle cefalosporiner.
CA1059991A (en) CEPHALOSPORINS HAVING A 7-(CARBOXY SUBSTITUTED .alpha.-ETHERIFIED OXIMINOARYLACETAMIDO) GROUP
US4492692A (en) Cephalosporin derivatives
US4385177A (en) Cephalosporins having a carbamoylalkoxyiminoarylacetamido group at 7-position
US4144392A (en) Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
KR830001130B1 (ko) 세팔로스포린 항생제의 제조방법
KR830001891B1 (ko) 세팔로스포린 항생물질의 제조방법
NL8001673A (nl) Cefalosporine-antibiotica.
US4162360A (en) 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
NL7907881A (nl) Nieuwe cefalosporine-antibiotica, werkwijze voor de bereiding daarvan en farmaceutische preparaten die deze bevatten.
KR870000611B1 (ko) 세팔로스포린의 제조방법
CA2053456C (en) Novel cephem compounds, their preparation processes and antibacterial agents
NL8501324A (nl) Cefalosporineantibiotica en werkwijze voor het bereiden en toepassen van deze antibiotica.
JPH07508274A (ja) アルファロスポリンおよび1−カルバ−1−デチアセファロスポリン